Overall, a significantly higher proportion of PBMCs were B cells (CD45+/CD19+) in BC patients than in healthy donors (11.51 ± 2.059 and 8.905 ± 0.379%, respectively; p = 0.001), with more variation seen in the patient group (Table 2 and Fig. 2). The gene discussed is CD19; the disease is breast cancer.